Topics - Cytotoxics and High Potency Manufacturing
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
By Tom Spurgeon, Contract Pharma
Published September 6, 2012
Fortune and opportunity in a burgeoning class of therapies Read More »
By Gil Y. Roth, Contract Pharma
Published May 4, 2012
Patheon's CEO talks about his first year on the job Read More »
Published April 4, 2012
More opportunities, but greater regulatory scrutiny Read More »
By Bernd Schummelfeder and Cristin Grove
Published April 4, 2012
Requirements for outsourcing high containment development activities Read More »
By Andrea Wagner
Published April 4, 2012
Pairing the product, package and process for parenterals Read More »
By Gil Roth
Published April 4, 2012
The president of Pfizer CentreSource talks about the company's move into development services. Read More »
By Gil Roth
Published March 7, 2012
Business is up while companies stake out new territories Read More »
By Gil Y. Roth
Published October 11, 2011
The CEO of Jubilant HollisterStier talks about integration Read More »
By Tom Patnaik
Published September 7, 2011
Production drives advances in equipment design Read More »
By Frank Generotzky
Published November 9, 2010
What to keep in mind with HPAI Outsourcing Read More »
